Daneryd, P., Aberg, F., Dallner, G., Ernster, L., Schersten, T. and Soussi,
B. (1995a) Coenzymes Q9 and Q10 in skeletal and cardiac muscle in tumour-bearing
exercising rats. European Journal of Cancer 331A, 760-765.
Daneryd, P., Hafstrom, L., Svanberg, E. and Karlberg, I. (1995b) Insulin
sensitivity, hormonal levels and skeletal muscle protein metabolism in
tumour-bearing exercising rats. European Journal of Cancer
Davies, K.J., Quintanilha, A.T., Brooks, G.A. and Packer, L. (1982) Free
radicals and tissue damage produced by exercise. Biochemical Biophysical
Researcg Communication 1107, 1198-1205.
Fairey, A.S., Courneya, K.S., Field, C.J. and Mackey, J.R. (2002) Physical
exercise and immune system function in cancer survivors: a comprehensive
review and future directions. Cancer 994, 539-551.
Finlay, C. A., Hinds, P. W. and Levine, A. J. (1989) The p53 proto-oncogene
can act as a suppressor of transformation. Cell 557, 1083-1093.
Foster, B.A., Coffey, H.A., Morin, M.J. and Rastinejad, F. (1999) Pharmacological
rescue of mutant p53 conformation and function. Science 2286,
Gerber, M. (2000) Oxidative stress, antioxidants and cancer. In: Handbook
of Oxidants and Antioxidants in Exercise. Eds: Sen, C.K, L. Packer,
L. and Hanninen, O. Amsterdam: Elsevier Sci. 927-949.
Hill, M.J. (1999) Diet, physical activity and cancer risk. Public Health
Nutrition 22, 397-401.
Inger, T. and Eiliv, L. (1997) Exercise and breast cancer. New England
Journal of Medicine 3337, 708-709.
Ji, L.L. (1999) Antioxidants and oxidative stress in exercise. Proceeding
Society Experimental Biology and Medicine 2222, 283-292.
Ji, L.L. and Hollander, J. (2000) Antioxidant enzyme defense: effects
of aging and exercise. In: Free Radicals in Exercise and Aging.
Ed: Radak, Z. Champaign, IL.: Human Kinetics. 35-72.
Kaelin, W.G., Jr. (1999) The p53 gene family. Oncogene 118,
Kiningham, R.B. (1998) Physical activity and the primary prevention of
cancer. Primary Care 225, 515-536.
Kritchevsky, D. (2001) Caloric restriction and cancer. Journal of Nutrition
Science and Vitaminology (Tokyo) 447, 13-19.
Lane, D.P. and Benchimol, S. (1990) p53: oncogene or anti-oncogene? Genes
Dev 44, 1-8.
Murphy, K.L., Dennis, A.P. and Rosen, J.M. (2000) A gain of function p53
mutant promotes both genomic instability and cell survival in a novel
p53-null mammary epithelial cell model. FASEB Journal 114,
Oren, M. (1992) p53: the ultimate tumor suppressor gene? FASEB Journal
Radak, Z., Asano, K., Lee, K. C., Ohno, H., Nakamura, A., Nakamoto, H.
and Goto, S. (1997) High altitude training increases reactive carbonyl
derivatives but not lipid peroxidation in skeletal muscle of rats. Free
Radical Biology and Medicine 222, 1109-1114.
Radak, Z. and Goto, S. (2000) Oxidative modification of proteins and DNA.
In: Free Radicals in Exercise and Aging. Ed: Radak, Z. Champaign,
IL.: Human Kinetics. 177-210.
Radak, Z., Kaneko, T., Tahara, S., Nakamoto, H., Ohno, H., Sasvari, M.,
Nyakas, C. and Goto, S. (1999) The effect of exercise training on oxidative
damage of lipids, proteins, and DNA in rat skeletal muscle: evidence for
beneficial outcomes. Free Radical Biology and Medicine 227,
Radak, Z., Taylor, A. W., Sasvari, M., Ohno, H., Horkay, B., Furesz, J.,
Gaal, D. and Kanel, T. (2001) Telomerase activity is not altered by regular
strenuous exercise in skeletal muscle or by sarcoma in liver of rats.
Redox Report 66, 99-103.
Shephard, R.J. and Futcher, R. (1997) Physical activity and cancer: how
may protection be maximized? Critcal Review of Oncogolgy 88,
Thompson, H.J. (1994) Effect of exercise intensity and duration on the
induction of mammary carcinogenesis. Cancer Research 554, 1960s-1963s.
Thompson, H.J., Westerlind, K. C., Snedden, J., Briggs, S. and Singh,
M. (1995) Exercise intensity dependent inhibition of 1-methyl-1-nitrosourea
induced mammary carcinogenesis in female F-344 rats. Carcinogenesis
Tomayko, M.M. and Reynolds, C.P. (1989) Determination of subcutaneous
tumor size in athymic (nude) mice. Cancer Chemotherapy and Pharmacology
Wiedmann, M.W. and Caca, K. (2005) Molecularly targeted therapy for gastrointestinal
cancer. Current Cancer Drug Targets 55, 171-193.
Wiedmann, M.W. and Mossner, J. (2010) Molecular targeted therapy of biliary
tract cancer--results of the first clinical studies. Current Cancer
Drug Targets 111, 834-850.
Zhang, Z., Li, J., Lantry, L.E., Wang, Y., Wiseman, R.W., Lubet, R.A.
and You, M. (2002) p53 transgenic mice are highly susceptible to 1, 2-dimethylhydrazine-induced
uterine sarcomas. Cancer Research 662, 3024-3029.